These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1187 related articles for article (PubMed ID: 10700176)
41. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin. Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523 [TBL] [Abstract][Full Text] [Related]
42. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin. Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974 [TBL] [Abstract][Full Text] [Related]
43. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling. Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752 [TBL] [Abstract][Full Text] [Related]
44. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574 [TBL] [Abstract][Full Text] [Related]
45. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex. Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804 [TBL] [Abstract][Full Text] [Related]
46. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146 [TBL] [Abstract][Full Text] [Related]
47. Beta-catenin mutation in carcinoma of the uterine endometrium. Fukuchi T; Sakamoto M; Tsuda H; Maruyama K; Nozawa S; Hirohashi S Cancer Res; 1998 Aug; 58(16):3526-8. PubMed ID: 9721853 [TBL] [Abstract][Full Text] [Related]
48. A common human skin tumour is caused by activating mutations in beta-catenin. Chan EF; Gat U; McNiff JM; Fuchs E Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393 [TBL] [Abstract][Full Text] [Related]
49. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma. Cui J; Zhou X; Liu Y; Tang Z; Romeih M Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479 [TBL] [Abstract][Full Text] [Related]
50. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629 [TBL] [Abstract][Full Text] [Related]
51. Adenomatous polyposis coli protein (APC)-independent regulation of beta-catenin/Tcf-4 mediated transcription in intestinal cells. Baulida J; Batlle E; García De Herreros A Biochem J; 1999 Dec; 344 Pt 2(Pt 2):565-70. PubMed ID: 10567241 [TBL] [Abstract][Full Text] [Related]
52. Signaling through beta-catenin and Lef/Tcf. Novak A; Dedhar S Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302 [TBL] [Abstract][Full Text] [Related]
53. Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression. Koppert LB; van der Velden AW; van de Wetering M; Abbou M; van den Ouweland AM; Tilanus HW; Wijnhoven BP; Dinjens WN Br J Cancer; 2004 Feb; 90(4):892-9. PubMed ID: 14970870 [TBL] [Abstract][Full Text] [Related]
54. Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma. Bläker H; Hofmann WJ; Rieker RJ; Penzel R; Graf M; Otto HF Genes Chromosomes Cancer; 1999 Aug; 25(4):399-402. PubMed ID: 10398436 [TBL] [Abstract][Full Text] [Related]
55. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Devereux TR; Anna CH; Foley JF; White CM; Sills RC; Barrett JC Oncogene; 1999 Aug; 18(33):4726-33. PubMed ID: 10467420 [TBL] [Abstract][Full Text] [Related]
56. Identification of Tcf4 residues involved in high-affinity beta-catenin binding. Omer CA; Miller PJ; Diehl RE; Kral AM Biochem Biophys Res Commun; 1999 Mar; 256(3):584-90. PubMed ID: 10080941 [TBL] [Abstract][Full Text] [Related]
57. Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma. Castiglia D; Bernardini S; Alvino E; Pagani E; De Luca N; Falcinelli S; Pacchiarotti A; Bonmassar E; Zambruno G; D'Atri S Genes Chromosomes Cancer; 2008 Jul; 47(7):614-24. PubMed ID: 18384130 [TBL] [Abstract][Full Text] [Related]
58. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Iwao K; Nakamori S; Kameyama M; Imaoka S; Kinoshita M; Fukui T; Ishiguro S; Nakamura Y; Miyoshi Y Cancer Res; 1998 Mar; 58(5):1021-6. PubMed ID: 9500465 [TBL] [Abstract][Full Text] [Related]
59. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388 [TBL] [Abstract][Full Text] [Related]
60. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells. Helmbrecht K; Kispert A; von Wasielewski R; Brabant G Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]